BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8778329)

  • 1. K-ras and p53 mutations in human colorectal aberrant crypt foci.
    Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
    J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
    Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S
    Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of X chromosome methylation in aberrant crypt foci of the human colon.
    Sakurazawa N; Tanaka N; Onda M; Esumi H
    Cancer Res; 2000 Jun; 60(12):3165-9. PubMed ID: 10866306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability in aberrant crypt foci from human colons.
    Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
    Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
    Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
    Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
    Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
    Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
    Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
    Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
    Hu Y; Le Leu RK; Young GP
    Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique.
    Habano W; Sugai T; Nakamura S; Yoshida T
    Lab Invest; 1996 May; 74(5):933-40. PubMed ID: 8642788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
    Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genome analyses for precancerous lesions in the gastrointestinal tract].
    Sowa M; Nakata B
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of aberrant crypt foci and microadenomas in human colon.
    Roncucci L; Medline A; Bruce WR
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic alterations of human colorectal cancer].
    Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.